☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
astraZeneca
AstraZeneca Reports the US FDA’s sNDA Acceptance of Calquence with Priority Review for Mantle Cell Lymphoma
October 3, 2024
AstraZeneca and Daiichi Sankyo Report the US FDA’s sBLA Acceptance of Enhertu with Priority Review to Treat HR+/HER2-low Metastati...
October 1, 2024
PharmaShots Weekly Snapshots (September 23 – September 27, 2024)
September 27, 2024
AstraZeneca’s Tagrisso Receives the US FDA’s Approval for Treating Unresectable, Stage III EGFR-Mutated Lung Cancer
September 26, 2024
AstraZeneca’s Fasenra Receives the CHMP’s Positive Opinion for Treating Eosinophilic Granulomatosis with Polyangiitis
September 24, 2024
AstraZeneca and Daiichi Sankyo Provide Update on the P-III (TROPION-Breast01) Study of Datopotamab Deruxtecan to Treat Breast Canc...
September 23, 2024
Load more...
Back to Home
Modal title
×
Modal body text goes here.